News

News and Press Releases
About the CF Foundation | Research | Drug Pipeline CF Foundation Announces Unprecedented Acceleration and Expansion of CF Research, Care and Patient Programs

The Cystic Fibrosis Foundation today announced an unprecedented acceleration and expansion of its research, care and patient programs for the CF community. This action is possible as a result of the sale of the Foundation's royalty rights to CF treatments developed by Vertex Pharmaceuticals Inc. The Foundation received $3.3 billion from the sale to Royalty Pharma.

| 3 min read
About the CF Foundation | Public Policy | Drug Pipeline CF Foundation Featured at Congressional Hearing on Patients’ Involvement in Drug Development

CF Foundation President and CEO Robert J. Beall, Ph.D. testified today before the House of Representatives' Energy and Commerce Committee at a hearing entitled, “21st Century Cures: Incorporating the Patient Perspective.”

| 2 min read
About the CF Foundation | Infection Prevention and Control Updated Infection Prevention and Control Guidelines for Cystic Fibrosis Now Published Online

A comprehensive, updated resource to assist the cystic fibrosis community with infection prevention and control practices is now available online. “Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update” will also be published in the August print edition of Infection Control & Hospital Epidemiology, the official journal of the Society for Healthcare Epidemiology of America.

| 2 min read